D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$510M |
| 2 |
Bank of America
BAC
|
+$395M |
| 3 |
Meta Platforms (Facebook)
META
|
+$365M |
| 4 |
Costco
COST
|
+$351M |
| 5 |
Procter & Gamble
PG
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$573M |
| 2 |
Advanced Micro Devices
AMD
|
+$405M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$387M |
| 4 |
Walmart Inc
WMT
|
+$364M |
| 5 |
Amazon
AMZN
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.38% |
| 2 | Financials | 10.31% |
| 3 | Healthcare | 7.77% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Industrials | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZVSA
2301
DELISTED
ZyVersa Therapeutics
ZVSA
| $3.84M | ﹤0.01% |
1,106
+667
| +152% | +$2.32M |
|
|
ECHO
2302
EchoStar
ECHO
$24.6B
| $3.84M | ﹤0.01% |
198,939
+188,502
| +1,806% | +$4.26M |
|
|
AMOD
2303
Alpha Modus Holdings
AMOD
$19.2M
| $3.84M | ﹤0.01% |
9,775
| – | – |
|
|
PET
2304
DELISTED
Wag!
PET
| $3.84M | ﹤0.01% |
386,061
| – | – |
|
2305
Factset
FDS
$9.31B
| $3.83M | ﹤0.01% |
9,973
+1,168
| +13% | +$457K |
|
2306
Hayward Holdings
HAYW
$3.24B
| $3.83M | ﹤0.01% |
266,147
-246,870
| -48% | -$3.81M |
|
2307
Moderna
MRNA
$23B
| $3.83M | ﹤0.01% |
26,814
-1,227,130
| -98% | -$175M |
|
2308
Celldex Therapeutics
CLDX
$2.97B
| $3.82M | ﹤0.01% |
141,720
+19,548
| +16% | +$568K |
|
2309
Dragonfly Energy
DFLI
$15M
| $3.82M | ﹤0.01% |
4,193
| – | – |
|
2310
GameStop
GME
$9.75B
| $3.81M | ﹤0.01% |
124,756
-2,812,856
| -96% | -$89.5M |
|
|
REVH
2311
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $3.81M | ﹤0.01% |
390,687
| – | – |
|
|
RVAC
2312
DELISTED
Riverview Acquisition Corp. Class A Common Stock
RVAC
| $3.81M | ﹤0.01% |
383,040
+50,000
| +15% | +$496K |
|
|
FTCH
2313
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $3.81M | ﹤0.01% |
532,000
-427,400
| -45% | -$4.37M |
|
|
IIII
2314
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $3.81M | ﹤0.01% |
386,300
+33,800
| +10% | +$332K |
|
|
EMBJ
2315
Embraer S.A. ADS
EMBJ
$11.9B
| $3.8M | ﹤0.01% |
+432,768
| New | +$4.63M |
|
2316
Alamos Gold
AGI
$11.6B
| $3.8M | ﹤0.01% |
540,962
-588,147
| -52% | -$4.58M |
|
2317
CALL
Las Vegas Sands
LVS
$31.7B
| $3.8M | ﹤0.01% |
113,000
-94,600
| -46% | -$3.27M |
|
2318
CALL
Appian
APPN
$1.96B
| $3.79M | ﹤0.01% |
80,000
-30,000
| -27% | -$1.51M |
|
2319
Assurant
AIZ
$13.9B
| $3.79M | ﹤0.01% |
21,913
-30,428
| -58% | -$5.51M |
|
2320
PUT
Bumble
BMBL
$370M
| $3.79M | ﹤0.01% |
134,500
-30,000
| -18% | -$815K |
|
2321
Werner Enterprises
WERN
$2.28B
| $3.78M | ﹤0.01% |
98,107
-129,223
| -57% | -$5.09M |
|
2322
Anavex Life Sciences
AVXL
$253M
| $3.78M | ﹤0.01% |
377,354
+67,962
| +22% | +$644K |
|
|
OMEG
2323
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $3.77M | ﹤0.01% |
383,131
+196,711
| +106% | +$1.94M |
|
2324
CDT Equity Inc
CDT
$1.64M
| – | – |
0
| – | – |
|
2325
Central Pacific Financial
CPF
$1.02B
| $3.76M | ﹤0.01% |
175,201
-41,512
| -19% | -$1.01M |
|
Similar funds
D.E. Shaw & Co's Q2 2022 Portfolio in Review
As of Q2 2022, D.E. Shaw & Co held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
D.E. Shaw & Co withdrew a net $8.24B in Q2 2022, closing 791 positions and reducing 1,836 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in iShares MSCI Emerging Markets ETF worth $171M.
- D.E. Shaw & Co's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
- D.E. Shaw & Co added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
- D.E. Shaw & Co's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
- D.E. Shaw & Co fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
- D.E. Shaw & Co's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
- D.E. Shaw & Co opened 596 new positions and closed 791 in Q2 2022.
- D.E. Shaw & Co's portfolio value fell 20% quarter-over-quarter to $85.3B.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.